The World Health Organisation (WHO) has also accepted Bharat Biotech’s Expression of Interest (EoI) for Covaxin and has scheduled a pre-submission meeting tomorrow (June 23). Bharat Biotech expects this to take Covaxin a step closer to getting a WHO emergency use listing (EUL).

Though the meeting will not be a detailed review of the Covaxin vaccine, Bharat Biotech will have an opportunity to submit a summary on the overall quality of the jab, according to the WHO.